Deoxycytidylic Acid Deaminase in Ehrlich Ascites Tumor Cells1'2

Total Page:16

File Type:pdf, Size:1020Kb

Deoxycytidylic Acid Deaminase in Ehrlich Ascites Tumor Cells1'2 Deoxycytidylic Acid Deaminase in Ehrlich Ascites Tumor Cells1'2 SILvI0 FIALA AND ANNA E. FIALA (Laboratory of Cell Physiology, Veterans Admini8tration Hospital, San Fernando, California and the Deparlment of Biochemistry, University of Southern California, Los Angeles, California) SUMMARY Ehrlich ascites tumor cells contain a highly active dCMP3-deaminase, but no de tectable dCMP-phosphatase. A stable dCMP-deaminase could be obtained in ex tracts, provided the ascitic fluid was washed from the cells. Inactivation occurred when the extracts were diluted. The experiments indicated that this was due to the dissociation of the enzyme followed, eventually, by an irreversible rearrangement of the protein moiety of the enzyme molecule. This dissociation seems to be preventedby the substrate, by dCTP or by heated extract. The linearity of dCMP-deaminase macti vation, with respect to time, indicated an interaction between the enzyme and inacti vating factors. This led to the discovery of 2 protein factors capable of inactivating dCMP-deaminase. One of the factors was found in the microsomes of various tissues, the other was a pseudoglobulin fraction from the ascitic fluid. In addition, orthophos phate and pyrophosphate were found to inactivate dCMP-deaminase. The inacti vating effect of all these compounds could be antagonized, but not reversed, by dCTP. dTTP not only inhibited dCMP-deaminase, in the presence of substrate, but also pro gressively inactivated dCMP-deaminase in the absence of substrate. In contrast to the above irreversible inactivators, however, the action of dTTP could be reversed by dCTP. The factors, encountered in extracts, may provide a rapid regulatory control of the activity of dCMP-deaminase. In addition, the reciprocal relationship between dCMP-deaminase and dCMP-phosphatase activities found in other tissues, indicates a slower regulation of these enzymatic activities by the genetic apparatus of the cell. Deoxycytidylic acid deaminase, the enzyme which con ordinately with cell multiplication. So far nothing definite verts dCMP to dUMP (13, 19), is present in mammalian is known about this regulation. Nevertheless, attempts tissues and manifests a high activity in such rapidly pro have been made to explain this phenomenon from data on liferating tissues as embryonic tissue or tumors (3, 13, 15, the conditions affecting the lability and stabilization of 19). In tissues with a low mitotic index, the activity of dCMP-deaminase in vitro. In the absence of substrate, the enzyme is quite low. Thus dCMP-deaminase activity this enzyme was reported to be inactivated by dialysis is low in adult rat liver but increases when cell proliferation and thermal denaturation (6) even by physiologic temper occurs in the organ, as for example after hepatectomy (14, atures (18, 20). The nature of this lability, however, is 17) or during carcinogenesis (3, 5). These circumstances not yet clear. Whereas one group of investigators con suggest that dCMP-deaminase plays an important role in sidered that the lability was caused by thermal denatur the chemical mechanism of cell proliferation and that the ation of the enzyme and contested the possibility that intracellular activity of this enzyme is regulated co dCMP-deaminase could be reactivated (20), another group reported a reactivation of inactive dCMP-deaminase 1 This work was presented, in part, at the Third Annual Meet ings of the American Society for Cell Biology, New York, N. Y., preparations (16). The finding that dCTP protected November, 1963. dCMP-deaminase against spontaneous inactivation in 2 This work was supported by grant-in-aid GB-754 from the vitro (16, 19, 20) while dTTP inhibited the enzyme led to National Science Foundation and by grant 07 171-01 from the the hypothesis of an enzymatic feed-back mechanism, National Cancer Institute. 3 The abbreviations used are : dCMP, deoxycytidylic acid; whereby these deoxynucleoside tniphosphates regulate dCTP, deoxycytidine triphosphate; dTTP, deoxythymidine tn dCMP-deaminase activity (16, 20, 21) by binding to an phosphate; dUMP, deoxyunidylic acid; P1, orthophosphate; ATP, allosteric site on the enzyme molecule (21). adenosine triphosphate ; GSH, reduced glutathione ; GSSG, oxi Despite these interesting data concerning the consti dized glutathione ; TMP, thymidylic acid ; GTP, guanosine tn phosphate. tution and properties of the enzyme, it seems clear that Received for publication October 5, 1964; revised March 1, the problem of in vivo regulation of dCMP-deaminase 1965. activity cannot be elucidated by observations on purified 922 Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 1965 American Association for Cancer Research. FIALA AND FIALA—dCMP Deaminase in Ehrlich Ascites Tumor Cells 923 enzyme preparations alone. The problem must also be glycyiglycine or 0.1 M Tnis buffer for 5—10mm at pH 7.0— approached by obtaining data of a more physiologic 7.2, we could solubilize all the dCMP-deaminase after 2 nature; that is, by studying the factors in homogenates extractions. In order to speed up the process, however, and tissue extracts which influence dCMP-deaminase ac only 1 extraction with 10 volumes of buffer was per tivity and correlating the levels of dCMP-deaminase formed. One milliliter of extract contained 20 mg pro activity under various physiologic conditions. Led by tein. During all the procedures prior to an experiment such considerations in our earlier work (7), we emphasized the material was kept in an ice-water bath. The “active the inverse relationship between the activities of dCMP extract― was used immediately or was stored at —15°Cfor deaminase and dCMP-phosphatase. The activity of several weeks without loss of activity. The advantage of dCMP-deaminase appeared to be proportional to the using acetone powders was that a fresh “activeextract― mitotic index of the tissue, while the activity of dCMP could be obtained at any time. On the other hand, only phosphatase seemed to parallel the generation time of the about one-third of the activity present in the intact cells cell (unpublished observations). We also reported earlier could be accounted for in the extracts, the remainder (6) thatmicrosomesfromvarioussourcescontaineda probably being lost during acetone homogenization of the factor, apparently a protein, which inactivated dCMP tissue. The extract made from 10 mg of powder con deaminase in the absence of substrate. In the present verted about 8 @imolesdCMP in 1 hr at 37°C. The work we have utilized homogenates and extracts of Ehrlich conditions of enzyme saturation were fulfilled when 0.1 ascites tumor cells to obtain more information about this ml of the extract (approximately 2 mg protein) was factor and about other aspects of the intracellular behavior incubation with 2 Mmoles dCMP. At this concentration of dCMP-deaminase. The main questions we have con the deamination of dCMP proceeded linearly for 30 mm sidered are the following: Under what conditions is dCMP at 37°Cand the amount of dCMP converted was propor deaminase stable and when is it labile? Which factors tional to the enzyme concentration. In a number of increase the stability and which increase the lability of the experiments we prepared a “heatedextract― and used it as enzyme? Finally, what conclusions can be drawn from a diluting medium for dCMP-deaminase. Such an extract these observations concerning the in vivo regulation of was prepared by heating acetone powdered cells in boiling dCMP-deaminase activity? water for 4 mm or, in later experiments, by heating to 70°C for 10 mm followed by centrifugation for 10 mm at 17,300 MATERIALS AND METHODS x g. TheheatedextractdidnowshowanydCMP Preparations of extracts from Ehrlich ascites carcinoma deaminase activity but contained nucleoside di- and cells.—Ehrlich ascites tumors obtained through the triphosphates as shown by paper electrophoresis. Deoxy courtesy of Dr. Franz A. Schmid (The Sloan Kettering nucleotides and nucleosides were purchased from Sigma Institute for Cancer Research, Rye, N. Y.), were trans Chemical Company, St. Louis, Mo. Reaction products mitted serially in Swiss albino mice (average weight 30 were followed by paper electrophoresis of KOH neutralized gm). Tumors were harvested 8—10days after inoculation, perchloric acid extracts in the model R Spinco electro yielding on the average 2.5 X 1O@cellsfrom a single mouse. phoresis cell (Durrum type) at constant voltage (200 The cell number counted in a Petroff-Hauser counter was volts) and current (4—7ma). Samples of 10—100 @lwere correlated with the optical densities measured at 520 m@s placed on Whatman No. 3MM paper strips and the eleetro (1 cm optical path) inaBeckmanmodel DUspectrophotom phoresis was performed at room temperature for 8 hr in eter. An optical density reading of 0.100 corresponded 0.5 M citrate buffer at pH 3.5. to 2.6 X 10@cells/mi, the cell number being a linear func Preparaiion of dCMP-deaminw@e inactivating factors tion of optical density in the range 0—20X 10@cells/mi. from ascitic fluid and microsomes.—The supernatant ob The cells were collected and centrifuged at 42 X g for 10 tamed after centrifuging the ascitic fluid at 3000 rpm was mm (0°C)followed by 2 resedimentations in 5—6volumes recentnifuged at the same speed for 10 mm and kept at of saline at 480 X g and 1085 X g. The resedimentation — 15°C. It was dialyzed before use in cellulose tubing for at 1085 X g was usually repeated to insure that the cells 24 hr at 2—4°Cagainst a large volume of distilled water. were completely washed. Bloody suspensions rarely The precipitate which formed was discarded. All the puri occurred and were rejected. For preparation of homog fication steps were performed at 0°C. For partial purl enates the cells were disrupted by ultrasonic vibration fication, the dialyzed material was brought to pH 5.0 with (20 kc, 10 sec at approximately 150 watts) with the diluted acetic acid and the precipitate, consisting mostly piezoelectric Sonifier 5-110 of Branson Instruments, Inc., of nucleic acids, was discarded.
Recommended publications
  • Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals
    Journal of the American Heart Association ORIGINAL RESEARCH Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals Joonatan Palmu , MD; Aaro Salosensaari , MSc; Aki S. Havulinna , DSc (Tech); Susan Cheng , MD, MPH; Michael Inouye, PhD; Mohit Jain, MD, PhD; Rodolfo A. Salido , BSc; Karenina Sanders , BSc; Caitriona Brennan, BSc; Gregory C. Humphrey, BSc; Jon G. Sanders , PhD; Erkki Vartiainen , MD, PhD; Tiina Laatikainen , MD, PhD; Pekka Jousilahti, MD, PhD; Veikko Salomaa , MD, PhD; Rob Knight , PhD; Leo Lahti , DSc (Tech); Teemu J. Niiranen , MD, PhD BACKGROUND: Several small-scale animal studies have suggested that gut microbiota and blood pressure (BP) are linked. However, results from human studies remain scarce and conflicting. We wanted to elucidate the multivariable-adjusted as- sociation between gut metagenome and BP in a large, representative, well-phenotyped population sample. We performed a focused analysis to examine the previously reported inverse associations between sodium intake and Lactobacillus abun- dance and between Lactobacillus abundance and BP. METHODS AND RESULTS: We studied a population sample of 6953 Finns aged 25 to 74 years (mean age, 49.2±12.9 years; 54.9% women). The participants underwent a health examination, which included BP measurement, stool collection, and 24-hour urine sampling (N=829). Gut microbiota was analyzed using shallow shotgun metagenome sequencing. In age- and sex-adjusted models, the α (within-sample) and β (between-sample) diversities of taxonomic composition were strongly re- lated to BP indexes (P<0.001 for most). In multivariable-adjusted models, β diversity was only associated with diastolic BP (P=0.032).
    [Show full text]
  • Supplementary Table S1. Table 1. List of Bacterial Strains Used in This Study Suppl
    Supplementary Material Supplementary Tables: Supplementary Table S1. Table 1. List of bacterial strains used in this study Supplementary Table S2. List of plasmids used in this study Supplementary Table 3. List of primers used for mutagenesis of P. intermedia Supplementary Table 4. List of primers used for qRT-PCR analysis in P. intermedia Supplementary Table 5. List of the most highly upregulated genes in P. intermedia OxyR mutant Supplementary Table 6. List of the most highly downregulated genes in P. intermedia OxyR mutant Supplementary Table 7. List of the most highly upregulated genes in P. intermedia grown in iron-deplete conditions Supplementary Table 8. List of the most highly downregulated genes in P. intermedia grown in iron-deplete conditions Supplementary Figures: Supplementary Figure 1. Comparison of the genomic loci encoding OxyR in Prevotella species. Supplementary Figure 2. Distribution of SOD and glutathione peroxidase genes within the genus Prevotella. Supplementary Table S1. Bacterial strains Strain Description Source or reference P. intermedia V3147 Wild type OMA14 isolated from the (1) periodontal pocket of a Japanese patient with periodontitis V3203 OMA14 PIOMA14_I_0073(oxyR)::ermF This study E. coli XL-1 Blue Host strain for cloning Stratagene S17-1 RP-4-2-Tc::Mu aph::Tn7 recA, Smr (2) 1 Supplementary Table S2. Plasmids Plasmid Relevant property Source or reference pUC118 Takara pBSSK pNDR-Dual Clonetech pTCB Apr Tcr, E. coli-Bacteroides shuttle vector (3) plasmid pKD954 Contains the Porpyromonas gulae catalase (4)
    [Show full text]
  • High Coverage Metabolomics Analysis Reveals Phage-Specific Alterations to Pseudomonas Aeruginosa Physiology During Infection
    The ISME Journal (2016) 10, 1823–1835 © 2016 International Society for Microbial Ecology All rights reserved 1751-7362/16 www.nature.com/ismej ORIGINAL ARTICLE High coverage metabolomics analysis reveals phage-specific alterations to Pseudomonas aeruginosa physiology during infection Jeroen De Smet1, Michael Zimmermann2, Maria Kogadeeva2, Pieter-Jan Ceyssens1,3, Wesley Vermaelen1, Bob Blasdel1, Ho Bin Jang1, Uwe Sauer2 and Rob Lavigne1 1Laboratory of Gene Technology, Department of Biosystems, KU Leuven, Heverlee, Belgium; 2Institute of Molecular Systems Biology, Eidgenössische Technische Hochschule (ETH) Zürich, Zürich, Switzerland and 3Unit Bacterial Diseases, Scientific Institute of Public Health (WIV-ISP), Brussels, Belgium Phage-mediated metabolic changes in bacteria are hypothesized to markedly alter global nutrient and biogeochemical cycles. Despite their theoretic importance, experimental data on the net metabolic impact of phage infection on the bacterial metabolism remains scarce. In this study, we tracked the dynamics of intracellular metabolites using untargeted high coverage metabolomics in Pseudomo- nas aeruginosa cells infected with lytic bacteriophages from six distinct phage genera. Analysis of the metabolomics data indicates an active interference in the host metabolism. In general, phages elicit an increase in pyrimidine and nucleotide sugar metabolism. Furthermore, clear phage-specific and infection stage-specific responses are observed, ranging from extreme metabolite depletion (for example, phage YuA) to complete reorganization of the metabolism (for example, phage phiKZ). As expected, pathways targeted by the phage-encoded auxiliary metabolic genes (AMGs) were enriched among the metabolites changing during infection. The effect on pyrimidine metabolism of phages encoding AMGs capable of host genome degradation (for example, YuA and LUZ19) was distinct from those lacking nuclease-encoding genes (for example, phiKZ), which demonstrates the link between the encoded set of AMGs of a phage and its impact on host physiology.
    [Show full text]
  • SUPPY Liglucosexlmtdh
    US 20100314248A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0314248 A1 Worden et al. (43) Pub. Date: Dec. 16, 2010 (54) RENEWABLE BOELECTRONIC INTERFACE Publication Classification FOR ELECTROBOCATALYTC REACTOR (51) Int. Cl. (76) Inventors: Robert M. Worden, Holt, MI (US); C25B II/06 (2006.01) Brian L. Hassler, Lake Orion, MI C25B II/2 (2006.01) (US); Lawrence T. Drzal, Okemos, GOIN 27/327 (2006.01) MI (US); Ilsoon Lee, Okemo s, MI BSD L/04 (2006.01) (US) C25B 9/00 (2006.01) (52) U.S. Cl. ............... 204/403.14; 204/290.11; 204/400; Correspondence Address: 204/290.07; 427/458; 204/252: 977/734; PRICE HENEVELD COOPER DEWITT & LIT 977/742 TON, LLP 695 KENMOOR, S.E., PO BOX 2567 (57) ABSTRACT GRAND RAPIDS, MI 495.01 (US) An inexpensive, easily renewable bioelectronic device useful for bioreactors, biosensors, and biofuel cells includes an elec (21) Appl. No.: 12/766,169 trically conductive carbon electrode and a bioelectronic inter face bonded to a surface of the electrically conductive carbon (22) Filed: Apr. 23, 2010 electrode, wherein the bioelectronic interface includes cata lytically active material that is electrostatically bound directly Related U.S. Application Data or indirectly to the electrically conductive carbon electrode to (60) Provisional application No. 61/172,337, filed on Apr. facilitate easy removal upon a change in pH, thereby allowing 24, 2009. easy regeneration of the bioelectronic interface. 7\ POWER 1 - SUPPY|- LIGLUCOSEXLMtDH?till pi 6.0 - esses&aaaas-exx-xx-xx-xx-xxxxixax-e- Patent Application Publication Dec. 16, 2010 Sheet 1 of 18 US 2010/0314248 A1 Potential (nV) Patent Application Publication Dec.
    [Show full text]
  • The Microbiota-Produced N-Formyl Peptide Fmlf Promotes Obesity-Induced Glucose
    Page 1 of 230 Diabetes Title: The microbiota-produced N-formyl peptide fMLF promotes obesity-induced glucose intolerance Joshua Wollam1, Matthew Riopel1, Yong-Jiang Xu1,2, Andrew M. F. Johnson1, Jachelle M. Ofrecio1, Wei Ying1, Dalila El Ouarrat1, Luisa S. Chan3, Andrew W. Han3, Nadir A. Mahmood3, Caitlin N. Ryan3, Yun Sok Lee1, Jeramie D. Watrous1,2, Mahendra D. Chordia4, Dongfeng Pan4, Mohit Jain1,2, Jerrold M. Olefsky1 * Affiliations: 1 Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA. 2 Department of Pharmacology, University of California, San Diego, La Jolla, California, USA. 3 Second Genome, Inc., South San Francisco, California, USA. 4 Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA. * Correspondence to: 858-534-2230, [email protected] Word Count: 4749 Figures: 6 Supplemental Figures: 11 Supplemental Tables: 5 1 Diabetes Publish Ahead of Print, published online April 22, 2019 Diabetes Page 2 of 230 ABSTRACT The composition of the gastrointestinal (GI) microbiota and associated metabolites changes dramatically with diet and the development of obesity. Although many correlations have been described, specific mechanistic links between these changes and glucose homeostasis remain to be defined. Here we show that blood and intestinal levels of the microbiota-produced N-formyl peptide, formyl-methionyl-leucyl-phenylalanine (fMLF), are elevated in high fat diet (HFD)- induced obese mice. Genetic or pharmacological inhibition of the N-formyl peptide receptor Fpr1 leads to increased insulin levels and improved glucose tolerance, dependent upon glucagon- like peptide-1 (GLP-1). Obese Fpr1-knockout (Fpr1-KO) mice also display an altered microbiome, exemplifying the dynamic relationship between host metabolism and microbiota.
    [Show full text]
  • 1611 REGULATION of PYRIMIDINE METABOLISM in PLANTS Chris
    [Frontiers in Bioscience 9, 1611-1625, May 1, 2004] REGULATION OF PYRIMIDINE METABOLISM IN PLANTS 1, 2 1, 3 1, 4 1, 5 1, 6 1, 7 Chris Kafer , Lan Zhou , Djoko Santoso , Adel Guirgis , Brock Weers , Sanggyu Park and Robert Thornburg 1 1 Department of Biochemistry, Biophysics, and Molecular Biology, Iowa State University, Ames, Iowa 50011, 2 BASF Plant Science LLC, 2901 South Loop Drive, Ste 3800, Ames, Iowa 50014, 3 Lan Zhou, Pioneer Hi-Bred International, Inc. 7300 NW 62nd Avenue, PO Box 1004, Johnston, Iowa 50131-1004, 4 Indonesian Biotechnology Research Institute for Estate Crops, Jl, Taman Kencana No 1, Bogor 16151 Indonesia, 5 Institute of Genetic Engineering and Biotechnology, Menofiya University, PO Box 79/22857, Sadat City, Egypt, 6 Department of Biochemistry, University of Iowa, 4/511 Bowen Science Building, Iowa City, Iowa 52242-1109, 7 Division of Life and Environment, College of Natural Resources, Daegu University, Gyongsan City, Gyongbuk, Korea 712-714 TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Pyrimidine metabolic pathways 3.1. De novo pyrimidine biosynthesis 3.1.1. CPSase 3.1.2. ATCase 3.1.3. DHOase 3.1.4. DHODH 3.1.5. UMPS 3.1.6. Intracellular Organization of the de novo Pathway 3.2. Pyrimidine Salvage and Recycling 3.2.1. Cytosine deaminase 3.2.2. Cytidine deaminase 3.2.3. UPRTase 3.3. Pyrimidine Modification 3.3.1. UMP/CMP kinase 3.3.2. NDP kinase 3.3.3. CTP synthase, NDP reductase, dUTPase 3.3.4. Thymidylate synthase/Dihydrofolate reductase 3.4. Pyrimidine Catabolism 4. Regulation of pyrimidine metabolism 4.1.
    [Show full text]
  • STRIPE2 Encodes a Putative Dcmp Deaminase That Plays an Important Role in Chloroplast Development in Rice
    Available online at www.sciencedirect.com ScienceDirect JGG Journal of Genetics and Genomics 41 (2014) 539e548 ORIGINAL RESEARCH STRIPE2 Encodes a Putative dCMP Deaminase that Plays an Important Role in Chloroplast Development in Rice Jing Xu a, Yiwen Deng a, Qun Li a, Xudong Zhu b,*, Zuhua He a,* a National Key Laboratory of Plant Molecular Genetics and National Center of Plant Gene Research, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai 200032, China b China National Rice Research Institute, Hangzhou 31006, China Received 31 March 2014; revised 8 May 2014; accepted 9 May 2014 Available online 19 June 2014 ABSTRACT Mutants with abnormal leaf coloration are good genetic materials for understanding the mechanism of chloroplast development and chlorophyll biosynthesis. In this study, a rice mutant st2 (stripe2) with stripe leaves was identified from the g-ray irradiated mutant pool. The st2 mutant exhibited decreased accumulation of chlorophyll and aberrant chloroplasts. Genetic analysis indicated that the st2 mutant was controlled by a single recessive locus. The ST2 gene was finely confined to a 27-kb region on chromosome 1 by the map-based cloning strategy and a 5-bp deletion in Os01g0765000 was identified by sequence analysis. The deletion happened in the joint of exon 3 and intron 3 and led to new spliced products of mRNA. Genetic complementation confirmed that Os01g0765000 is the ST2 gene. We found that the ST2 gene was expressed ubiquitously. Subcellular localization assay showed that the ST2 protein was located in mitochondria. ST2 belongs to the cytidine deaminase-like family and possibly functions as the dCMP deaminase, which catalyzes the formation of dUMP from dCMP by deamination.
    [Show full text]
  • The Metabolic Building Blocks of a Minimal Cell Supplementary
    The metabolic building blocks of a minimal cell Mariana Reyes-Prieto, Rosario Gil, Mercè Llabrés, Pere Palmer and Andrés Moya Supplementary material. Table S1. List of enzymes and reactions modified from Gabaldon et. al. (2007). n.i.: non identified. E.C. Name Reaction Gil et. al. 2004 Glass et. al. 2006 number 2.7.1.69 phosphotransferase system glc + pep → g6p + pyr PTS MG041, 069, 429 5.3.1.9 glucose-6-phosphate isomerase g6p ↔ f6p PGI MG111 2.7.1.11 6-phosphofructokinase f6p + atp → fbp + adp PFK MG215 4.1.2.13 fructose-1,6-bisphosphate aldolase fbp ↔ gdp + dhp FBA MG023 5.3.1.1 triose-phosphate isomerase gdp ↔ dhp TPI MG431 glyceraldehyde-3-phosphate gdp + nad + p ↔ bpg + 1.2.1.12 GAP MG301 dehydrogenase nadh 2.7.2.3 phosphoglycerate kinase bpg + adp ↔ 3pg + atp PGK MG300 5.4.2.1 phosphoglycerate mutase 3pg ↔ 2pg GPM MG430 4.2.1.11 enolase 2pg ↔ pep ENO MG407 2.7.1.40 pyruvate kinase pep + adp → pyr + atp PYK MG216 1.1.1.27 lactate dehydrogenase pyr + nadh ↔ lac + nad LDH MG460 1.1.1.94 sn-glycerol-3-phosphate dehydrogenase dhp + nadh → g3p + nad GPS n.i. 2.3.1.15 sn-glycerol-3-phosphate acyltransferase g3p + pal → mag PLSb n.i. 2.3.1.51 1-acyl-sn-glycerol-3-phosphate mag + pal → dag PLSc MG212 acyltransferase 2.7.7.41 phosphatidate cytidyltransferase dag + ctp → cdp-dag + pp CDS MG437 cdp-dag + ser → pser + 2.7.8.8 phosphatidylserine synthase PSS n.i. cmp 4.1.1.65 phosphatidylserine decarboxylase pser → peta PSD n.i.
    [Show full text]
  • Developmental Disorder Associated with Increased Cellular Nucleotidase Activity (Purine-Pyrimidine Metabolism͞uridine͞brain Diseases)
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 11601–11606, October 1997 Medical Sciences Developmental disorder associated with increased cellular nucleotidase activity (purine-pyrimidine metabolismyuridineybrain diseases) THEODORE PAGE*†,ALICE YU‡,JOHN FONTANESI‡, AND WILLIAM L. NYHAN‡ Departments of *Neurosciences and ‡Pediatrics, University of California at San Diego, La Jolla, CA 92093 Communicated by J. Edwin Seegmiller, University of California at San Diego, La Jolla, CA, August 7, 1997 (received for review June 26, 1997) ABSTRACT Four unrelated patients are described with a represent defects of purine metabolism, although no specific syndrome that included developmental delay, seizures, ataxia, enzyme abnormality has been identified in these cases (6). In recurrent infections, severe language deficit, and an unusual none of these disorders has it been possible to delineate the behavioral phenotype characterized by hyperactivity, short mechanism through which the enzyme deficiency produces the attention span, and poor social interaction. These manifesta- neurological or behavioral abnormalities. Therapeutic strate- tions appeared within the first few years of life. Each patient gies designed to treat the behavioral and neurological abnor- displayed abnormalities on EEG. No unusual metabolites were malities of these disorders by replacing the supposed deficient found in plasma or urine, and metabolic testing was normal metabolites have not been successful in any case. except for persistent hypouricosuria. Investigation of purine This report describes four unrelated patients in whom and pyrimidine metabolism in cultured fibroblasts derived developmental delay, seizures, ataxia, recurrent infections, from these patients showed normal incorporation of purine speech deficit, and an unusual behavioral phenotype were bases into nucleotides but decreased incorporation of uridine.
    [Show full text]
  • 1 SUPPLEMENTARY INFORMATION 1 2 an Archaeal Symbiont
    1 SUPPLEMENTARY INFORMATION 2 3 An archaeal symbiont-host association from the deep terrestrial subsurface 4 5 Katrin Schwank1, Till L. V. Bornemann1, Nina Dombrowski2, Anja Spang2,3, Jillian F. Banfield4 and 6 Alexander J. Probst1* 7 8 9 1 Group for Aquatic Microbial Ecology (GAME), Biofilm Center, Department of Chemistry, 10 University of Duisburg-Essen, Germany 11 2Department of Marine Microbiology and Biogeochemistry (MMB), Royal Netherlands Institute 12 for Sea Research (NIOZ), and Utrecht University, Den Burg, Netherlands 13 3Department of Cell- and Molecular Biology, Science for Life Laboratory, Uppsala University, SE- 14 75123, Uppsala, Sweden 15 4 Department for Earth and Planetary Sciences, University of California, Berkeley, USA 16 17 *to whom the correspondence should be addressed: 18 Alexander J. Probst 19 University of Duisburg-Essen 20 Universitätsstrasse 4 21 45141 Essen 22 [email protected] 23 24 25 Content: 26 1. Supplementary Methods 27 2. Supplementary Tables 28 3. Supplementary Figure 29 4. References 30 31 32 33 1. Supplementary methods 34 Phylogenetic analysis 35 Hmm profiles of the 37 maker genes used by the phylosift v1.01 software [1, 2] were queried 36 against a representative set of archaeal genomes from NCBI (182) and the GOLD database (3) as 37 well as against the huberarchaeal population genome (for details on genomes please see 38 Supplementary Data file 1) using the phylosift search mode [1, 2]. Protein sequences 39 corresponding to each of the maker genes were subsequently aligned using mafft-linsi v7.407 [3] 40 and trimmed with BMGE-1.12 (parameters: -t AA -m BLOSUM30 -h 0.55) [4].
    [Show full text]
  • Behavior of Opposing Pathways of Thymidine Utilization in Differentiating, Regenerating, and Neoplastic Liver1
    CANCER RESEARCH 31, 550-556, May 1971) Behavior of Opposing Pathways of Thymidine Utilization in Differentiating, Regenerating, and Neoplastic Liver1 John A. Ferdinandus, Harold P. Morris, and George Weber2 Department of Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana 46202 /J. A. F., G. W.¡,and Department of Biochemistry, Howard University College of Medicine, Washington, D. C. 2000 Ì[H.P. M.¡ SUMMARY expression in cancer cells (20, 24). The identification of the pattern should provide the investigator with an understanding The behavior of opposing pathways of thymidine utilization of the progressive metabolic changes that relate to neoplastic was compared in proliferating normal liver (from developing proliferation rate. The Molecular Correlation Concept rats and from partially hepatectomized rats) and in neoplastic developed in this laboratory postulated the existence of a liver (spectrum of hepatomas of different growth rates). The meaningful biochemical pattern, which may be understood studies were carried out by assaying simultaneously the when a number of preconditions are satisfied (21). Among incorporation of labeled thymidine into DNA (synthetic these preconditions is the need to obtain an insight into the pathway) and the degradation to C02 (catabolic pathway) in regulation of opposing synthetic and catabolic pathways and tissue slices in an in vitro system. key enzymes and to elucidate their relationship with tumor In the liver of newborn rats, the incorporation of thymidine growth rate. For example, it was recognized that the activity into DNA is very high and gradually decreases during of the key glycolytic enzymes increased and concurrently the differentiation to very low levels in the adult.
    [Show full text]
  • O O2 Enzymes Available from Sigma Enzymes Available from Sigma
    COO 2.7.1.15 Ribokinase OXIDOREDUCTASES CONH2 COO 2.7.1.16 Ribulokinase 1.1.1.1 Alcohol dehydrogenase BLOOD GROUP + O O + O O 1.1.1.3 Homoserine dehydrogenase HYALURONIC ACID DERMATAN ALGINATES O-ANTIGENS STARCH GLYCOGEN CH COO N COO 2.7.1.17 Xylulokinase P GLYCOPROTEINS SUBSTANCES 2 OH N + COO 1.1.1.8 Glycerol-3-phosphate dehydrogenase Ribose -O - P - O - P - O- Adenosine(P) Ribose - O - P - O - P - O -Adenosine NICOTINATE 2.7.1.19 Phosphoribulokinase GANGLIOSIDES PEPTIDO- CH OH CH OH N 1 + COO 1.1.1.9 D-Xylulose reductase 2 2 NH .2.1 2.7.1.24 Dephospho-CoA kinase O CHITIN CHONDROITIN PECTIN INULIN CELLULOSE O O NH O O O O Ribose- P 2.4 N N RP 1.1.1.10 l-Xylulose reductase MUCINS GLYCAN 6.3.5.1 2.7.7.18 2.7.1.25 Adenylylsulfate kinase CH2OH HO Indoleacetate Indoxyl + 1.1.1.14 l-Iditol dehydrogenase L O O O Desamino-NAD Nicotinate- Quinolinate- A 2.7.1.28 Triokinase O O 1.1.1.132 HO (Auxin) NAD(P) 6.3.1.5 2.4.2.19 1.1.1.19 Glucuronate reductase CHOH - 2.4.1.68 CH3 OH OH OH nucleotide 2.7.1.30 Glycerol kinase Y - COO nucleotide 2.7.1.31 Glycerate kinase 1.1.1.21 Aldehyde reductase AcNH CHOH COO 6.3.2.7-10 2.4.1.69 O 1.2.3.7 2.4.2.19 R OPPT OH OH + 1.1.1.22 UDPglucose dehydrogenase 2.4.99.7 HO O OPPU HO 2.7.1.32 Choline kinase S CH2OH 6.3.2.13 OH OPPU CH HO CH2CH(NH3)COO HO CH CH NH HO CH2CH2NHCOCH3 CH O CH CH NHCOCH COO 1.1.1.23 Histidinol dehydrogenase OPC 2.4.1.17 3 2.4.1.29 CH CHO 2 2 2 3 2 2 3 O 2.7.1.33 Pantothenate kinase CH3CH NHAC OH OH OH LACTOSE 2 COO 1.1.1.25 Shikimate dehydrogenase A HO HO OPPG CH OH 2.7.1.34 Pantetheine kinase UDP- TDP-Rhamnose 2 NH NH NH NH N M 2.7.1.36 Mevalonate kinase 1.1.1.27 Lactate dehydrogenase HO COO- GDP- 2.4.1.21 O NH NH 4.1.1.28 2.3.1.5 2.1.1.4 1.1.1.29 Glycerate dehydrogenase C UDP-N-Ac-Muramate Iduronate OH 2.4.1.1 2.4.1.11 HO 5-Hydroxy- 5-Hydroxytryptamine N-Acetyl-serotonin N-Acetyl-5-O-methyl-serotonin Quinolinate 2.7.1.39 Homoserine kinase Mannuronate CH3 etc.
    [Show full text]